Journal ArticleOPEN ACCESS

Anti-IL5 therapies for chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews (2019) 2019(9)
DOI: 10.1002/14651858.cd013432
50Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of monoclonal antibody therapies targeting IL-5 signalling (anti-IL-5 or anti-IL-5Rα) compared with placebo in the treatment of adults with COPD.

Cite

CITATION STYLE

APA

Donovan, T., Crossingham, I., Milan, S. J., Wang, R., & Bradley, P. (2019). Anti-IL5 therapies for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 2019(9). https://doi.org/10.1002/14651858.cd013432

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free